InSure ONE Test

Looking for ways to improve patient satisfaction? InSure ONE's collection method prioritizes patient comfort and dignity during colorectal screening. Click the link below and make the switch for a happier patient population. https://hubs.ly/Q02p6hm-0 #PatientSatisfaction #InSureONE

A 2022 study identified common CRC screening barriers among hospitalized women. ⚕   The study identified the most common barriers as 1.    I have other problems more important than getting a colonoscopy 2.    No transportation to get to the test 3.    Not counseled by primary care provider   The study also mentions 66% of the non-adherent women would agree to have an inpatient screening colonoscopy if offered.   Main points of the study: 1.    A significant number of hospitalized women are non-adherent to colorectal cancer screening guidelines 2.    Offering inpatient colorectal cancer screening to non-adherent patients may lower the burden of cancer screening disparities among women, especially those who are at high risk. 3.    Lack of transportation and not being counseled by primary care are among the major barriers to screening. A majority (66%) of non-adherent women are amenable to inpatient screening colonoscopy if offered during a hospital stay.   Source: Graham H, Kauffman R, Khaliq W. Colorectal Cancer Screening Prevalence, Perceived Barriers, and Preference for Screening Colonoscopy Among Hospitalized Women. Turk J Gastroenterol. 2022 Nov;33(11):901-908. doi: 10.5152/tjg.2022.21567. PMID: 35946889; PMCID: PMC9797704.

A recent study explored the cost of noninvasive screening modalities for colorectal cancer and found the rate of early stage (stage 0 to II) disease was found to be similar between those screened with FIT and muli-target stool DNA test (59.5% FIT vs 63.2% multi-target stool DNA test; p=0.77).   The research findings suggest that implementing FIT as the primary noninvasive colorectal cancer (CRC) screening method could yield substantial cost savings and hold significant value implications for extensive population health systems.   1.    Allen CJ, Bloom N, Rothka M, et al. Comprehensive cost implications of commercially available noninvasive colorectal cancer screening modalities. J Am Coll Surg. 2023;10. doi:10.1097/XCS.0000000000000768

No patient likes handling their own poop even if it is to test for blood in their stool. InSure ONE removes the need for patients to scoop the poop during sample collection. With InSure ONE you collect two water based samples using our long handled blue brushes. Are you interested in using InSure ONE for your patients? Click this link and speak with someone today. https://hubs.ly/Q02p63Ns0 #dontscoopthepoop #insureone #earlydetection

Did you know? The US Preventative Services Task Force, American College of Gastroenterology, and the US Multi-Society Task Force on Colorectal Cancer guidelines recommend o  Annual FIT o  Colonoscopy every 10 years   Visit insuretest.com to discover how InSure ONE can serve as an invaluable tool for colorectal screening in your healthcare facility.   Click here to meet with our team: https://lnkd.in/ewu-s3zw   1.    US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965-1977. doi:10.1001/jama.2021.6238   2.    Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: Colorectal Cancer Screening 2021. Am J Gastroenterol. 2021;116(3):458-479. doi:10.14309/ajg.000000000000122   3.    Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030. doi:10.1038/ ajg.2017.174

Did you know? Colorectal cancer (CRC) has the second-highest death rate among cancers but over 30% of adults ages 50-75 are not getting screened as recommended. Visit https://hubs.ly/Q02p5vN20 to discover how InSure ONE can serve as an invaluable tool for colorectal screening in your healthcare facility. Click here to meet with our team: https://hubs.ly/Q02p5_4C0 1. Siegel RL, Wagle NS, Cercek A, Smith, RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73(3):233-254. doi:10.3322/caac.21772 2. Data & Progress. National Colorectal Cancer Roundtable. May 10, 2023. Accessed July 11, 2023. https://hubs.ly/Q02p5Tk-0

Did you know that InSure ONE offers a more patient-centric approach to FIT for colorectal screening? Our long handled brushes eliminate the need for patients to scoop the poop during sample collection. Click the link below and discover how our innovative collection method can benefit your healthcare facility and your patients. https://hubs.ly/Q02p63Pk0 #HealthcareAdvancements #InSureONE

Did you know? >1 in 3 Adults ages 45+ not screened for colorectal cancer per recommendations. Visit https://hubs.ly/Q02p5kYk0 to discover how InSure ONE can serve as an invaluable tool for colorectal screening in your healthcare facility. Click here to meet with our team: https://hubs.ly/Q02p5qR80 1. Data & Progress. National Colorectal Cancer Roundtable. May 10, 2023. Accessed July 11, 2023. https://hubs.ly/Q02p5S6Y0

Explore Our FIT (Fecal Immunochemical Test), a Patient-Friendly Colorectal Screening Option. With no dietary or medication restrictions and no clinic visits required, it offers unparalleled convenience. Interested in learning more. Visit https://hubs.ly/Q02psy8M0 or speak with someone today https://hubs.ly/Q02psg8m0

🔍 Healthcare professionals, staying informed about the diverse risk factors for colorectal cancer is essential for providing top-notch care. Check out this infographic breaking down both lifestyle and non-lifstyle related risk factors. Stay up to date to empower your patient care. #ColorectalCancerAwareness #HealthcareProfessionals #MedicalResearch Sources: - https://lnkd.in/ePjjWg37 - https://hubs.ly/Q02mJJX20. - https://hubs.ly/Q02mJKQb0 - https://lnkd.in/eR_A9q4b - https://hubs.ly/Q02mJL8C0